Display options
Share it on

Clinics (Sao Paulo). 2021 Nov 26;76:e3488. doi: 10.6061/clinics/2021/e3488. eCollection 2021.

Differences in children and adolescents with SARS-CoV-2 infection: a cohort study in a Brazilian tertiary referral hospital.

Clinics (Sao Paulo, Brazil)

Heloisa Helena de Sousa Marques, Maria Fernanda Badue Pereira, Angélica Carreira Dos Santos, Thais Toledo Fink, Camila Sanson Yoshino de Paula, Nadia Litvinov, Claudio Schvartsman, Artur Figueiredo Delgado, Maria Augusta Bento Cicaroni Gibelli, Werther Brunow de Carvalho, Vicente Odone Filho, Uenis Tannuri, Magda Carneiro-Sampaio, Sandra Grisi, Alberto José da Silva Duarte, Leila Antonangelo, Rossana Pucineli Vieira Francisco, Thelma Suely Okay, Linamara Rizzo Batisttella, Carlos Roberto Ribeiro de Carvalho, Alexandra Valéria Maria Brentani, Clovis Artur Silva, Adriana Pasmanik Eisencraft, Alfio Rossi Junior, Alice Lima Fante, Aline Pivetta Cora, Amelia Gorete A de Costa Reis, Ana Paula Scoleze Ferrer, Anarella Penha Meirelles de Andrade, Andreia Watanabe, Angelina Maria Freire Gonçalves, Aurora Rosaria Pagliara Waetge, Camila Altenfelder Silva, Carina Ceneviva, Carolina Dos Santos Lazari, Deipara Monteiro Abellan, Emilly Henrique Dos Santos, Ester Cerdeira Sabino, Fabíola Roberta Marim Bianchini, Flávio Ferraz de Paes Alcantara, Gabriel Frizzo Ramos, Gabriela Nunes Leal, Isadora Souza Rodriguez, João Renato Rebello Pinho, Jorge David Avaizoglou Carneiro, Jose Albino Paz, Juliana Carvalho Ferreira, Juliana Ferreira Ferranti, Juliana de Oliveira Achili Ferreira, Juliana Valéria de Souza Framil, Katia Regina da Silva, Kelly Aparecida Kanunfre, Karina Lucio de Medeiros Bastos, Karine Vusberg Galleti, Lilian Maria Cristofani, Lisa Suzuki, Lucia Maria Arruda Campos, Maria Beatriz de Moliterno Perondi, Maria de Fatima Rodrigues Diniz, Maria Fernanda Mota Fonseca, Mariana Nutti de Almeida Cordon, Mariana Pissolato, Marina Silva Peres, Marlene Pereira Garanito, Marta Imamura, Mayra de Barros Dorna, Michele Luglio, Mussya Cisotto Rocha, Nadia Emi Aikawa, Natalia Viu Degaspare, Neusa Keico Sakita, Nicole Lee Udsen, Paula Gobi Scudeller, Paula Vieira de Vincenzi Gaiolla, Rafael da Silva Giannasi Severini, Regina Maria Rodrigues, Ricardo Katsuya Toma, Ricardo Iunis Citrangulo de Paula, Patricia Palmeira, Silvana Forsait, Sylvia Costa Lima Farhat, Tânia Miyuki Shimoda Sakano, Vera Hermina Kalika Koch, Vilson Cobello Junior

Affiliations

  1. Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR.
  2. Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, SP, BR.

PMID: 34852143 PMCID: PMC8595603 DOI: 10.6061/clinics/2021/e3488

Abstract

OBJECTIVES: To compare demographic/clinical/laboratory/treatments and outcomes among children and adolescents with laboratory-confirmed coronavirus disease 2019 (COVID-19).

METHODS: This was a cross-sectional study that included patients diagnosed with pediatric COVID-19 (aged <18 years) between April 11, 2020 and April 22, 2021. During this period, 102/5,951 (1.7%) of all admissions occurred in neonates, children, and adolescents. Furthermore, 3,962 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection samples were processed in patients aged <18 years, and laboratory-confirmed COVID-19 occurred in 155 (4%) inpatients and outpatients. Six/155 pediatric patients were excluded from the study. Therefore, the final group included 149 children and adolescents (n=97 inpatients and 52 outpatients) with positive SARS-CoV-2 results.

RESULTS: The frequencies of sore throat, anosmia, dysgeusia, headache, myalgia, nausea, lymphopenia, pre-existing chronic conditions, immunosuppressive conditions, and autoimmune diseases were significantly reduced in children and adolescents (p<0.05). Likewise, the frequencies of enoxaparin use (p=0.037), current immunosuppressant use (p=0.008), vasoactive agents (p=0.045), arterial hypotension (p<0.001), and shock (p=0.024) were significantly lower in children than in adolescents. Logistic regression analysis showed that adolescents with laboratory-confirmed COVID-19 had increased odds ratios (ORs) for sore throat (OR 13.054; 95% confidence interval [CI] 2.750-61.977; p=0.001), nausea (OR 8.875; 95% CI 1.660-47.446; p=0.011), and lymphopenia (OR 3.575; 95% CI 1.355-9.430; p=0.010), but also had less hospitalizations (OR 0.355; 95% CI 0.138-0.916; p=0.032). The additional logistic regression analysis on patients with preexisting chronic conditions (n=108) showed that death as an outcome was significantly associated with pediatric severe acute respiratory syndrome (SARS) (OR 22.300; 95% CI 2.341-212.421; p=0.007) and multisystem inflammatory syndrome in children (MIS-C) (OR 11.261; 95% CI 1.189-106. 581; p=0.035).

CONCLUSIONS: Half of the laboratory-confirmed COVID-19 cases occurred in adolescents. Individuals belonging to this age group had an acute systemic involvement of SARS-CoV-2 infection. Pediatric SARS and MIS-C were the most important factors associated with the mortality rate in pediatric chronic conditions with COVID-19.

References

  1. BMJ Open. 2021 Jun 30;11(6):e051706 - PubMed
  2. JAMA Pediatr. 2020 Oct 1;174(10):e202430 - PubMed
  3. Rev Paul Pediatr. 2019 Nov 25;38:e2018101 - PubMed
  4. Virol Sin. 2020 Dec;35(6):803-810 - PubMed
  5. Braz J Infect Dis. 2020 Nov - Dec;24(6):570-574 - PubMed
  6. J Infect Dis. 2021 Feb 13;223(3):362-369 - PubMed
  7. Science. 2021 May 21;372(6544):815-821 - PubMed
  8. Acta Paediatr. 2020 Nov;109(11):2311-2312 - PubMed
  9. Clinics (Sao Paulo). 2021 Mar 24;76:e2688 - PubMed
  10. J Pediatric Infect Dis Soc. 2020 Dec 31;9(6):772-776 - PubMed
  11. J Trop Pediatr. 2021 Jul 2;67(3): - PubMed
  12. Pediatr Radiol. 2021 Feb;51(2):239-247 - PubMed
  13. Theranostics. 2020 May 15;10(14):6372-6383 - PubMed
  14. MMWR Morb Mortal Wkly Rep. 2021 Jun 11;70(23):851-857 - PubMed
  15. Clinics (Sao Paulo). 2020 Jun 03;75:e1986 - PubMed
  16. Am J Transl Res. 2020 Apr 15;12(4):1348-1354 - PubMed
  17. J Pediatr (Rio J). 2018 Sep - Oct;94(5):539-545 - PubMed
  18. Lupus. 2021 Apr;30(5):856-860 - PubMed
  19. Euro Surveill. 2020 Jan;25(3): - PubMed
  20. Int J Infect Dis. 2021 Jun;107:78-85 - PubMed
  21. J Clin Virol. 2020 Aug;129:104468 - PubMed
  22. Pediatr Pulmonol. 2021 Jun;56(6):1332-1341 - PubMed
  23. Arq Bras Cardiol. 2021 Nov;117(5):954-964 - PubMed
  24. Clinics (Sao Paulo). 2020;75:e1947 - PubMed
  25. Int J Infect Dis. 2021 Apr;105:723-729 - PubMed
  26. J Pediatr (Rio J). 2021 Jun 12;: - PubMed
  27. J Pediatr. 2020 Aug;223:14-19.e2 - PubMed
  28. Clinics (Sao Paulo). 2020;75:e2209 - PubMed
  29. Lancet Microbe. 2021 Oct;2(10):e527-e535 - PubMed
  30. J Infect Public Health. 2021 Mar;14(3):374-379 - PubMed
  31. Clinics (Sao Paulo). 2020;75:e2294 - PubMed
  32. J Pediatr (Rio J). 2019 Nov - Dec;95(6):667-673 - PubMed
  33. Clinics (Sao Paulo). 2020 Nov 30;75:e2273 - PubMed
  34. J Infect. 2021 Jul;83(1):e22-e25 - PubMed
  35. Clinics (Sao Paulo). 2020;75:e1931 - PubMed
  36. Clinics (Sao Paulo). 2020 Jun 03;75:e1996 - PubMed
  37. EClinicalMedicine. 2021 May;35:100850 - PubMed
  38. Lupus. 2020 Dec;29(14):1978-1980 - PubMed
  39. Lancet Child Adolesc Health. 2020 Oct;4(10):790-794 - PubMed
  40. Clinics (Sao Paulo). 2020 Jun 29;75:e2100 - PubMed
  41. Rev Paul Pediatr. 2020 Sep 07;39:e2020192 - PubMed

Publication Types